Health Impact Investing Accounting

Health Impact Investing Accounting: Financial Reporting for Investments in Health

Improvement Initiatives

Introduction

Health impact investing has emerged as an innovative financing strategy that applies

principles of impact measurement and evaluation to investments made specifically to

improve health outcomes and reduce healthcare costs. By directing capital into initiatives

proven to lower disease burden and generate savings for healthcare systems, impact

investors accept potentially lower financial returns on a risk-adjusted basis in exchange for

clear positive social returns in the form of improved health, wellbeing and health equity.

The first accounting challenge lies in clearly classifying various types of health impact

investments in a standardized, non-ambiguous manner compatible with existing financial

reporting guidelines. Options could include designation as a separate hybrid asset class

acknowledging both financial return goals alongside health objectives. Alternatively,

investments may be categorized within existing groups (e.g. as a Subtype of program-

related, mission-related, or ESG investments) provided non-financial goals receive

prominence in performance assessment. Clear definitions separating health impact

investments from generic development or philanthropic activities establish consistent

nomenclature and avoid blurring impact mandate accountabilities when blended portfolios

exist.

contingent valuation surveys, willingness-to-pay estimates, or disability-adjusted life years

avoided provide defensible proxies. Metrics must factor in time lags between interventions

and ultimate outcomes realized. Metric selections ensure consistency assessing portfolios

while flexibility addresses context-specific impacts. Finally, both quantitative and qualitative

impact reporting, with reasonable due diligence documentation substantiating impact claims

maintains transparency and comparability of social returns realized.

Attributing and Benchmarking Financial Returns

While impact goals prevail, financial sustainability requires reasonable risk-adjusted returns

on invested capital over time. Calculating risk-adjusted return metrics considers volatility and

downside protection important given potential income inconsistencies from preventive,

upstream initiatives. Multivariate attribution analyses apportion returns across impact

performance and market/sector factors to isolate value added from impact mandate versus

secular trends. Health impact investments may benchmark risk-returns against public

classes based on characteristics. Overall, consistent attribution frameworks and peer

comparisons reinforce health impact investment propositions amongst mainstream investors.

Impact Measurement Standardization and Assurance

Reliable measurement forms the cornerstone of substantiating impact claims central to

practices akin to financial auditing assurance adds rigor enabling mainstream asset

allocations.

Regulatory and Taxonomic Alignment

Varied regulatory environments and taxonomies potentially inhibit consistent sector

definition, reporting norms and investment strategies harmonization across jurisdictions.

Coordinated efforts aligning health impact investing within existing frameworks like the EU

Sustainable Finance Taxonomy or USA STARS rating system would facilitate solutions

proposed earlier around classification, benchmarking and metrics standards while respecting

While health impact investing emerges, prudent stewardship ensures its promise as a

scalable tool driving real-world health improvements responsibly. Specific investment

guidelines framing appropriate due diligence, risk-management practices, governance

structures and impact-first decision making foster uptake especially among larger regulated

institutions like pension funds or sovereign wealth vehicles seeking scalable health-aligned

allocations. Pilots demonstrating proof of concept ease initial conservatism, as do

Simultaneously, research quantifying longer term cost-offsets realized through prevention-

focused approaches strengthen business cases for dedicated health impact investing

allocation levels within larger ESG mandates over time. Overall, judicious incubation

supports mainstreaming of this holistic value-creation strategy.

Discussion

As health impact investing evolves, progress hinges on establishing rigorous yet inclusive

performance assessment standards enabling equitable comparisons and prudent oversight.

independent verification crystallize accountability, replicability and substantive impact claims

central to all prudent investments. Regulatory and industry alignment optimized for health

maximize enabling environments channeling greater resources into proven solutions.

Overall, careful stewardship balances rigor with the flexibility innovation requires, cultivating

scalability necessary to fulfill health impact investing's immense potential as a population

health strategy. With time and experience, diligent standard-setting nurtures maturation

attribution analyses and independent verification buttress all claims central to consequential

investments. Regulatory and industry alignments maximizing health-focused potential

complement rigorous standards. With experience, judicious standard-setting offsets risks

amid innovation, sustaining allocation growth that scales successful initiatives worldwide. By

establishing stakeholder confidence through transparency and comparability, diligent

accounting practices cultivate health impact investing as a mainstream tool driving

substantive, lasting population health advances through market solutions aligned with

investors’ duties. Overall, accounting rigor builds the discipline enabling this impactful

strategy to fulfill its promise responsibly.

and non-financial performance metrics of health-focused impact funds and investment

portfolios. This paper explores considerations for financial reporting standards that would

strengthen the rigor, accountability and scalability of health impact investing.

Classifying Health Impact Investments

investments in a standardized, non-ambiguous manner compatible with existing financial

reporting guidelines. Options could include designation as a separate hybrid asset class

acknowledging both financial return goals alongside health objectives. Alternatively,

investments may be categorized within existing groups (e.g. as a Subtype of program-

related, mission-related, or ESG investments) provided non-financial goals receive

prominence in performance assessment. Clear definitions separating health impact

investments from generic development or philanthropic activities establish consistent

nomenclature and avoid blurring impact mandate accountabilities when blended portfolios

Valuing and Reporting on Social Returns

Beyond financial performance data, standardized health and social metrics frameworks must

quantify investment achievements against both medical and broader societal outcomes

envisioned. Such metrics may track common diseases prevented, healthcare costs averted,

Attributing and Benchmarking Financial Returns

While impact goals prevail, financial sustainability requires reasonable risk-adjusted returns

on invested capital over time. Calculating risk-adjusted return metrics considers volatility and

downside protection important given potential income inconsistencies from preventive,

upstream initiatives. Multivariate attribution analyses apportion returns across impact

performance and market/sector factors to isolate value added from impact mandate versus

secular trends. Health impact investments may benchmark risk-returns against public

equities, tax-exempt bonds, or composite indices incorporating other mission-driven asset

evaluation and continuous quality improvement. Independent, third-party validation of

progress reported toward impact goals further bolsters integrity, comparability and reliability

expected of financial stakeholders. Emerging international standards like the Impact

Reporting and Investment Standards (IRIS) Catalog, aligned with SDG indicators may serve

as a coherent foundation for standardized metrics definitions and rating assurance

applicable across health impact portfolios globally. Overall, standardized measurement

allocations.

Regulatory and Taxonomic Alignment

Varied regulatory environments and taxonomies potentially inhibit consistent sector

definition, reporting norms and investment strategies harmonization across jurisdictions.

Coordinated efforts aligning health impact investing within existing frameworks like the EU

Sustainable Finance Taxonomy or USA STARS rating system would facilitate solutions

jurisdictional nuances. Additionally, regulatory clarity on ancillary favorable tax treatment,

pooled vehicles eligibility, accreditation of verifiers and rating agencies etc. strengthen the

value proposition and scalability of health impact investing among accredited institutions

subject to prudential oversight. Overall, carefully regulated alignment optimizes enabling

environments for channeling greater capital into highest-priority health issues effectively.

investment vehicles, funds of funds and advisory services lowering barriers to entry.

Simultaneously, research quantifying longer term cost-offsets realized through prevention-

focused approaches strengthen business cases for dedicated health impact investing

allocation levels within larger ESG mandates over time. Overall, judicious incubation

supports mainstreaming of this holistic value-creation strategy.

Discussion

As health impact investing evolves, progress hinges on establishing rigorous yet inclusive

performance assessment standards enabling equitable comparisons and prudent oversight.

Classification clarity, comprehensive yet standardized metrics, attribution analyses and

Conclusion

In closing, for health impact investing to responsibly deliver on its promise as a strategy for

improved societal wellbeing, prudent accounting standards play an invaluable role in

substantiating performance, clarifying mandates and strengthening oversight. Clear

classification, standardized yet holistic metrics quantifying varied impacts, rigorous

investments. Regulatory and industry alignments maximizing health-focused potential

complement rigorous standards. With experience, judicious standard-setting offsets risks

amid innovation, sustaining allocation growth that scales successful initiatives worldwide. By

establishing stakeholder confidence through transparency and comparability, diligent

accounting practices cultivate health impact investing as a mainstream tool driving

substantive, lasting population health advances through market solutions aligned with

investors’ duties. Overall, accounting rigor builds the discipline enabling this impactful

strategy to fulfill its promise responsibly.

Health impact investing has emerged as an innovative financing strategy that applies

principles of impact measurement and evaluation to investments made specifically to

improve health outcomes and reduce healthcare costs. By directing capital into initiatives

proven to lower disease burden and generate savings for healthcare systems, impact

investors accept potentially lower financial returns on a risk-adjusted basis in exchange for

clear positive social returns in the form of improved health, wellbeing and health equity.

The first accounting challenge lies in clearly classifying various types of health impact

investments in a standardized, non-ambiguous manner compatible with existing financial

reporting guidelines. Options could include designation as a separate hybrid asset class

acknowledging both financial return goals alongside health objectives. Alternatively,

investments may be categorized within existing groups (e.g. as a Subtype of program-

related, mission-related, or ESG investments) provided non-financial goals receive

prominence in performance assessment. Clear definitions separating health impact

investments from generic development or philanthropic activities establish consistent

nomenclature and avoid blurring impact mandate accountabilities when blended portfolios

exist.

contingent valuation surveys, willingness-to-pay estimates, or disability-adjusted life years

avoided provide defensible proxies. Metrics must factor in time lags between interventions

and ultimate outcomes realized. Metric selections ensure consistency assessing portfolios

while flexibility addresses context-specific impacts. Finally, both quantitative and qualitative

impact reporting, with reasonable due diligence documentation substantiating impact claims

maintains transparency and comparability of social returns realized.

Attributing and Benchmarking Financial Returns

While impact goals prevail, financial sustainability requires reasonable risk-adjusted returns

on invested capital over time. Calculating risk-adjusted return metrics considers volatility and

downside protection important given potential income inconsistencies from preventive,

upstream initiatives. Multivariate attribution analyses apportion returns across impact

performance and market/sector factors to isolate value added from impact mandate versus

secular trends. Health impact investments may benchmark risk-returns against public

classes based on characteristics. Overall, consistent attribution frameworks and peer

comparisons reinforce health impact investment propositions amongst mainstream investors.

Impact Measurement Standardization and Assurance

Reliable measurement forms the cornerstone of substantiating impact claims central to

practices akin to financial auditing assurance adds rigor enabling mainstream asset

allocations.

Regulatory and Taxonomic Alignment

Varied regulatory environments and taxonomies potentially inhibit consistent sector

definition, reporting norms and investment strategies harmonization across jurisdictions.

Coordinated efforts aligning health impact investing within existing frameworks like the EU

Sustainable Finance Taxonomy or USA STARS rating system would facilitate solutions

proposed earlier around classification, benchmarking and metrics standards while respecting

While health impact investing emerges, prudent stewardship ensures its promise as a

scalable tool driving real-world health improvements responsibly. Specific investment

guidelines framing appropriate due diligence, risk-management practices, governance

structures and impact-first decision making foster uptake especially among larger regulated

institutions like pension funds or sovereign wealth vehicles seeking scalable health-aligned

allocations. Pilots demonstrating proof of concept ease initial conservatism, as do

Simultaneously, research quantifying longer term cost-offsets realized through prevention-

focused approaches strengthen business cases for dedicated health impact investing

allocation levels within larger ESG mandates over time. Overall, judicious incubation

supports mainstreaming of this holistic value-creation strategy.

Discussion

As health impact investing evolves, progress hinges on establishing rigorous yet inclusive

performance assessment standards enabling equitable comparisons and prudent oversight.

independent verification crystallize accountability, replicability and substantive impact claims

central to all prudent investments. Regulatory and industry alignment optimized for health

maximize enabling environments channeling greater resources into proven solutions.

Overall, careful stewardship balances rigor with the flexibility innovation requires, cultivating

scalability necessary to fulfill health impact investing's immense potential as a population

health strategy. With time and experience, diligent standard-setting nurtures maturation

attribution analyses and independent verification buttress all claims central to consequential

investments. Regulatory and industry alignments maximizing health-focused potential

complement rigorous standards. With experience, judicious standard-setting offsets risks

amid innovation, sustaining allocation growth that scales successful initiatives worldwide. By

establishing stakeholder confidence through transparency and comparability, diligent

accounting practices cultivate health impact investing as a mainstream tool driving

substantive, lasting population health advances through market solutions aligned with

investors’ duties. Overall, accounting rigor builds the discipline enabling this impactful

strategy to fulfill its promise responsibly.

and non-financial performance metrics of health-focused impact funds and investment

portfolios. This paper explores considerations for financial reporting standards that would

strengthen the rigor, accountability and scalability of health impact investing.

Classifying Health Impact Investments

investments in a standardized, non-ambiguous manner compatible with existing financial

reporting guidelines. Options could include designation as a separate hybrid asset class

acknowledging both financial return goals alongside health objectives. Alternatively,

investments may be categorized within existing groups (e.g. as a Subtype of program-

related, mission-related, or ESG investments) provided non-financial goals receive

prominence in performance assessment. Clear definitions separating health impact

investments from generic development or philanthropic activities establish consistent

nomenclature and avoid blurring impact mandate accountabilities when blended portfolios

Valuing and Reporting on Social Returns

Beyond financial performance data, standardized health and social metrics frameworks must

quantify investment achievements against both medical and broader societal outcomes

envisioned. Such metrics may track common diseases prevented, healthcare costs averted,

Attributing and Benchmarking Financial Returns

While impact goals prevail, financial sustainability requires reasonable risk-adjusted returns

on invested capital over time. Calculating risk-adjusted return metrics considers volatility and

downside protection important given potential income inconsistencies from preventive,

upstream initiatives. Multivariate attribution analyses apportion returns across impact

performance and market/sector factors to isolate value added from impact mandate versus

secular trends. Health impact investments may benchmark risk-returns against public

equities, tax-exempt bonds, or composite indices incorporating other mission-driven asset

evaluation and continuous quality improvement. Independent, third-party validation of

progress reported toward impact goals further bolsters integrity, comparability and reliability

expected of financial stakeholders. Emerging international standards like the Impact

Reporting and Investment Standards (IRIS) Catalog, aligned with SDG indicators may serve

as a coherent foundation for standardized metrics definitions and rating assurance

applicable across health impact portfolios globally. Overall, standardized measurement

allocations.

Regulatory and Taxonomic Alignment

accounting practices cultivate health impact investing as a mainstream tool driving

substantive, lasting population health advances through market solutions aligned with

investors’ duties. Overall, accounting rigor builds the discipline enabling this impactful

strategy to fulfill its promise responsibly.

Health impact investing has emerged as an innovative financing strategy that applies

principles of impact measurement and evaluation to investments made specifically to

improve health outcomes and reduce healthcare costs. By directing capital into initiatives

proven to lower disease burden and generate savings for healthcare systems, impact

investors accept potentially lower financial returns on a risk-adjusted basis in exchange for

clear positive social returns in the form of improved health, wellbeing and health equity.

The first accounting challenge lies in clearly classifying various types of health impact

investments in a standardized, non-ambiguous manner compatible with existing financial

reporting guidelines. Options could include designation as a separate hybrid asset class

acknowledging both financial return goals alongside health objectives. Alternatively,

investments may be categorized within existing groups (e.g. as a Subtype of program-

related, mission-related, or ESG investments) provided non-financial goals receive

prominence in performance assessment. Clear definitions separating health impact

investments from generic development or philanthropic activities establish consistent

nomenclature and avoid blurring impact mandate accountabilities when blended portfolios

exist.

contingent valuation surveys, willingness-to-pay estimates, or disability-adjusted life years

avoided provide defensible proxies. Metrics must factor in time lags between interventions

and ultimate outcomes realized. Metric selections ensure consistency assessing portfolios

while flexibility addresses context-specific impacts. Finally, both quantitative and qualitative

impact reporting, with reasonable due diligence documentation substantiating impact claims

maintains transparency and comparability of social returns realized.

Attributing and Benchmarking Financial Returns

While impact goals prevail, financial sustainability requires reasonable risk-adjusted returns

on invested capital over time. Calculating risk-adjusted return metrics considers volatility and

downside protection important given potential income inconsistencies from preventive,

upstream initiatives. Multivariate attribution analyses apportion returns across impact

performance and market/sector factors to isolate value added from impact mandate versus

secular trends. Health impact investments may benchmark risk-returns against public

classes based on characteristics. Overall, consistent attribution frameworks and peer

comparisons reinforce health impact investment propositions amongst mainstream investors.

Impact Measurement Standardization and Assurance

Reliable measurement forms the cornerstone of substantiating impact claims central to

practices akin to financial auditing assurance adds rigor enabling mainstream asset

allocations.

Regulatory and Taxonomic Alignment

Varied regulatory environments and taxonomies potentially inhibit consistent sector

definition, reporting norms and investment strategies harmonization across jurisdictions.

Coordinated efforts aligning health impact investing within existing frameworks like the EU

Sustainable Finance Taxonomy or USA STARS rating system would facilitate solutions

proposed earlier around classification, benchmarking and metrics standards while respecting

While health impact investing emerges, prudent stewardship ensures its promise as a

scalable tool driving real-world health improvements responsibly. Specific investment

guidelines framing appropriate due diligence, risk-management practices, governance

structures and impact-first decision making foster uptake especially among larger regulated

institutions like pension funds or sovereign wealth vehicles seeking scalable health-aligned

allocations. Pilots demonstrating proof of concept ease initial conservatism, as do

Simultaneously, research quantifying longer term cost-offsets realized through prevention-

focused approaches strengthen business cases for dedicated health impact investing

allocation levels within larger ESG mandates over time. Overall, judicious incubation

supports mainstreaming of this holistic value-creation strategy.

Discussion

As health impact investing evolves, progress hinges on establishing rigorous yet inclusive

performance assessment standards enabling equitable comparisons and prudent oversight.

independent verification crystallize accountability, replicability and substantive impact claims

central to all prudent investments. Regulatory and industry alignment optimized for health

maximize enabling environments channeling greater resources into proven solutions.

Overall, careful stewardship balances rigor with the flexibility innovation requires, cultivating

scalability necessary to fulfill health impact investing's immense potential as a population

health strategy. With time and experience, diligent standard-setting nurtures maturation

attribution analyses and independent verification buttress all claims central to consequential

investments. Regulatory and industry alignments maximizing health-focused potential

complement rigorous standards. With experience, judicious standard-setting offsets risks

amid innovation, sustaining allocation growth that scales successful initiatives worldwide. By

establishing stakeholder confidence through transparency and comparability, diligent

accounting practices cultivate health impact investing as a mainstream tool driving

substantive, lasting population health advances through market solutions aligned with

investors’ duties. Overall, accounting rigor builds the discipline enabling this impactful

strategy to fulfill its promise responsibly.

and non-financial performance metrics of health-focused impact funds and investment

portfolios. This paper explores considerations for financial reporting standards that would

strengthen the rigor, accountability and scalability of health impact investing.

Classifying Health Impact Investments

investments in a standardized, non-ambiguous manner compatible with existing financial

reporting guidelines. Options could include designation as a separate hybrid asset class

acknowledging both financial return goals alongside health objectives. Alternatively,

investments may be categorized within existing groups (e.g. as a Subtype of program-

related, mission-related, or ESG investments) provided non-financial goals receive

prominence in performance assessment. Clear definitions separating health impact

investments from generic development or philanthropic activities establish consistent

nomenclature and avoid blurring impact mandate accountabilities when blended portfolios

Valuing and Reporting on Social Returns

Beyond financial performance data, standardized health and social metrics frameworks must

quantify investment achievements against both medical and broader societal outcomes

envisioned. Such metrics may track common diseases prevented, healthcare costs averted,

Attributing and Benchmarking Financial Returns

While impact goals prevail, financial sustainability requires reasonable risk-adjusted returns

on invested capital over time. Calculating risk-adjusted return metrics considers volatility and

downside protection important given potential income inconsistencies from preventive,

upstream initiatives. Multivariate attribution analyses apportion returns across impact

performance and market/sector factors to isolate value added from impact mandate versus

secular trends. Health impact investments may benchmark risk-returns against public

equities, tax-exempt bonds, or composite indices incorporating other mission-driven asset

evaluation and continuous quality improvement. Independent, third-party validation of

progress reported toward impact goals further bolsters integrity, comparability and reliability

expected of financial stakeholders. Emerging international standards like the Impact

Reporting and Investment Standards (IRIS) Catalog, aligned with SDG indicators may serve

as a coherent foundation for standardized metrics definitions and rating assurance

applicable across health impact portfolios globally. Overall, standardized measurement

allocations.

Regulatory and Taxonomic Alignment

Varied regulatory environments and taxonomies potentially inhibit consistent sector

definition, reporting norms and investment strategies harmonization across jurisdictions.

Coordinated efforts aligning health impact investing within existing frameworks like the EU

Sustainable Finance Taxonomy or USA STARS rating system would facilitate solutions

jurisdictional nuances. Additionally, regulatory clarity on ancillary favorable tax treatment,

pooled vehicles eligibility, accreditation of verifiers and rating agencies etc. strengthen the

value proposition and scalability of health impact investing among accredited institutions

subject to prudential oversight. Overall, carefully regulated alignment optimizes enabling

environments for channeling greater capital into highest-priority health issues effectively.

investment vehicles, funds of funds and advisory services lowering barriers to entry.

Simultaneously, research quantifying longer term cost-offsets realized through prevention-

focused approaches strengthen business cases for dedicated health impact investing

allocation levels within larger ESG mandates over time. Overall, judicious incubation

supports mainstreaming of this holistic value-creation strategy.

Discussion

As health impact investing evolves, progress hinges on establishing rigorous yet inclusive

performance assessment standards enabling equitable comparisons and prudent oversight.

Classification clarity, comprehensive yet standardized metrics, attribution analyses and

Conclusion

In closing, for health impact investing to responsibly deliver on its promise as a strategy for

improved societal wellbeing, prudent accounting standards play an invaluable role in

substantiating performance, clarifying mandates and strengthening oversight. Clear

classification, standardized yet holistic metrics quantifying varied impacts, rigorous

investments. Regulatory and industry alignments maximizing health-focused potential

complement rigorous standards. With experience, judicious standard-setting offsets risks

amid innovation, sustaining allocation growth that scales successful initiatives worldwide. By

establishing stakeholder confidence through transparency and comparability, diligent

accounting practices cultivate health impact investing as a mainstream tool driving

substantive, lasting population health advances through market solutions aligned with

investors’ duties. Overall, accounting rigor builds the discipline enabling this impactful

strategy to fulfill its promise responsibly.

Health impact investing has emerged as an innovative financing strategy that applies

principles of impact measurement and evaluation to investments made specifically to

improve health outcomes and reduce healthcare costs. By directing capital into initiatives

proven to lower disease burden and generate savings for healthcare systems, impact

investors accept potentially lower financial returns on a risk-adjusted basis in exchange for

clear positive social returns in the form of improved health, wellbeing and health equity.

The first accounting challenge lies in clearly classifying various types of health impact

investments in a standardized, non-ambiguous manner compatible with existing financial

reporting guidelines. Options could include designation as a separate hybrid asset class

acknowledging both financial return goals alongside health objectives. Alternatively,

investments may be categorized within existing groups (e.g. as a Subtype of program-

related, mission-related, or ESG investments) provided non-financial goals receive

prominence in performance assessment. Clear definitions separating health impact

investments from generic development or philanthropic activities establish consistent

nomenclature and avoid blurring impact mandate accountabilities when blended portfolios

exist.

contingent valuation surveys, willingness-to-pay estimates, or disability-adjusted life years

avoided provide defensible proxies. Metrics must factor in time lags between interventions

and ultimate outcomes realized. Metric selections ensure consistency assessing portfolios

while flexibility addresses context-specific impacts. Finally, both quantitative and qualitative

impact reporting, with reasonable due diligence documentation substantiating impact claims

maintains transparency and comparability of social returns realized.

Attributing and Benchmarking Financial Returns

While impact goals prevail, financial sustainability requires reasonable risk-adjusted returns

on invested capital over time. Calculating risk-adjusted return metrics considers volatility and

downside protection important given potential income inconsistencies from preventive,

upstream initiatives. Multivariate attribution analyses apportion returns across impact

performance and market/sector factors to isolate value added from impact mandate versus

secular trends. Health impact investments may benchmark risk-returns against public

classes based on characteristics. Overall, consistent attribution frameworks and peer

comparisons reinforce health impact investment propositions amongst mainstream investors.

Impact Measurement Standardization and Assurance

Reliable measurement forms the cornerstone of substantiating impact claims central to

practices akin to financial auditing assurance adds rigor enabling mainstream asset

allocations.

Regulatory and Taxonomic Alignment

Varied regulatory environments and taxonomies potentially inhibit consistent sector

definition, reporting norms and investment strategies harmonization across jurisdictions.

Coordinated efforts aligning health impact investing within existing frameworks like the EU

Sustainable Finance Taxonomy or USA STARS rating system would facilitate solutions

proposed earlier around classification, benchmarking and metrics standards while respecting

While health impact investing emerges, prudent stewardship ensures its promise as a

scalable tool driving real-world health improvements responsibly. Specific investment

guidelines framing appropriate due diligence, risk-management practices, governance

structures and impact-first decision making foster uptake especially among larger regulated

institutions like pension funds or sovereign wealth vehicles seeking scalable health-aligned

allocations. Pilots demonstrating proof of concept ease initial conservatism, as do

Simultaneously, research quantifying longer term cost-offsets realized through prevention-

focused approaches strengthen business cases for dedicated health impact investing

allocation levels within larger ESG mandates over time. Overall, judicious incubation

supports mainstreaming of this holistic value-creation strategy.

Discussion

As health impact investing evolves, progress hinges on establishing rigorous yet inclusive

performance assessment standards enabling equitable comparisons and prudent oversight.

independent verification crystallize accountability, replicability and substantive impact claims

central to all prudent investments. Regulatory and industry alignment optimized for health

maximize enabling environments channeling greater resources into proven solutions.

Overall, careful stewardship balances rigor with the flexibility innovation requires, cultivating

scalability necessary to fulfill health impact investing's immense potential as a population

health strategy. With time and experience, diligent standard-setting nurtures maturation

attribution analyses and independent verification buttress all claims central to consequential

investments. Regulatory and industry alignments maximizing health-focused potential

complement rigorous standards. With experience, judicious standard-setting offsets risks

amid innovation, sustaining allocation growth that scales successful initiatives worldwide. By

establishing stakeholder confidence through transparency and comparability, diligent

accounting practices cultivate health impact investing as a mainstream tool driving

substantive, lasting population health advances through market solutions aligned with

investors’ duties. Overall, accounting rigor builds the discipline enabling this impactful

strategy to fulfill its promise responsibly.

and non-financial performance metrics of health-focused impact funds and investment

portfolios. This paper explores considerations for financial reporting standards that would

strengthen the rigor, accountability and scalability of health impact investing.

Classifying Health Impact Investments

investments in a standardized, non-ambiguous manner compatible with existing financial

reporting guidelines. Options could include designation as a separate hybrid asset class

acknowledging both financial return goals alongside health objectives. Alternatively,

investments may be categorized within existing groups (e.g. as a Subtype of program-

related, mission-related, or ESG investments) provided non-financial goals receive

prominence in performance assessment. Clear definitions separating health impact

investments from generic development or philanthropic activities establish consistent

nomenclature and avoid blurring impact mandate accountabilities when blended portfolios

Valuing and Reporting on Social Returns

Beyond financial performance data, standardized health and social metrics frameworks must

quantify investment achievements against both medical and broader societal outcomes

envisioned. Such metrics may track common diseases prevented, healthcare costs averted,

Attributing and Benchmarking Financial Returns

While impact goals prevail, financial sustainability requires reasonable risk-adjusted returns

on invested capital over time. Calculating risk-adjusted return metrics considers volatility and

downside protection important given potential income inconsistencies from preventive,

upstream initiatives. Multivariate attribution analyses apportion returns across impact

performance and market/sector factors to isolate value added from impact mandate versus

secular trends. Health impact investments may benchmark risk-returns against public

equities, tax-exempt bonds, or composite indices incorporating other mission-driven asset

evaluation and continuous quality improvement. Independent, third-party validation of

progress reported toward impact goals further bolsters integrity, comparability and reliability

expected of financial stakeholders. Emerging international standards like the Impact

Reporting and Investment Standards (IRIS) Catalog, aligned with SDG indicators may serve

as a coherent foundation for standardized metrics definitions and rating assurance

applicable across health impact portfolios globally. Overall, standardized measurement

allocations.

Regulatory and Taxonomic Alignment

Varied regulatory environments and taxonomies potentially inhibit consistent sector

definition, reporting norms and investment strategies harmonization across jurisdictions.

Coordinated efforts aligning health impact investing within existing frameworks like the EU

Sustainable Finance Taxonomy or USA STARS rating system would facilitate solutions

jurisdictional nuances. Additionally, regulatory clarity on ancillary favorable tax treatment,

pooled vehicles eligibility, accreditation of verifiers and rating agencies etc. strengthen the

value proposition and scalability of health impact investing among accredited institutions

subject to prudential oversight. Overall, carefully regulated alignment optimizes enabling

environments for channeling greater capital into highest-priority health issues effectively.

investment vehicles, funds of funds and advisory services lowering barriers to entry.

Simultaneously, research quantifying longer term cost-offsets realized through prevention-

focused approaches strengthen business cases for dedicated health impact investing

allocation levels within larger ESG mandates over time. Overall, judicious incubation

supports mainstreaming of this holistic value-creation strategy.

Discussion

As health impact investing evolves, progress hinges on establishing rigorous yet inclusive

performance assessment standards enabling equitable comparisons and prudent oversight.

Classification clarity, comprehensive yet standardized metrics, attribution analyses and

Conclusion

In closing, for health impact investing to responsibly deliver on its promise as a strategy for

improved societal wellbeing, prudent accounting standards play an invaluable role in

substantiating performance, clarifying mandates and strengthening oversight. Clear

classification, standardized yet holistic metrics quantifying varied impacts, rigorous

investments. Regulatory and industry alignments maximizing health-focused potential

complement rigorous standards. With experience, judicious standard-setting offsets risks

amid innovation, sustaining allocation growth that scales successful initiatives worldwide. By

establishing stakeholder confidence through transparency and comparability, diligent